Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis

Abstract Background Lipopolysaccharide, a highly potent endotoxin responsible for severe sepsis, is the major constituent of the outer membrane of gram-negative bacteria. Endothelial cells participate in both innate and adaptive immune responses as the first cell types to detect lipopolysaccharide o...

Full description

Bibliographic Details
Main Authors: Min Wang, Jun Feng, Daixing Zhou, Junshuai Wang
Format: Article
Language:English
Published: BMC 2023-09-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-023-01301-5
_version_ 1797577289934831616
author Min Wang
Jun Feng
Daixing Zhou
Junshuai Wang
author_facet Min Wang
Jun Feng
Daixing Zhou
Junshuai Wang
author_sort Min Wang
collection DOAJ
description Abstract Background Lipopolysaccharide, a highly potent endotoxin responsible for severe sepsis, is the major constituent of the outer membrane of gram-negative bacteria. Endothelial cells participate in both innate and adaptive immune responses as the first cell types to detect lipopolysaccharide or other foreign debris in the bloodstream. Endothelial cells are able to recognize the presence of LPS and recruit specific adaptor proteins to the membrane domains of TLR4, thereby initiating an intracellular signaling cascade. However, lipopolysaccharide binding to endothelial cells induces endothelial activation and even damage, manifested by the expression of proinflammatory cytokines and adhesion molecules that lead to sepsis. Main findings LPS is involved in both local and systemic inflammation, activating both innate and adaptive immunity. Translocation of lipopolysaccharide into the circulation causes endotoxemia. Endothelial dysfunction, including exaggerated inflammation, coagulopathy and vascular leakage, may play a central role in the dysregulated host response and pathogenesis of sepsis. By discussing the many strategies used to treat sepsis, this review attempts to provide an overview of how lipopolysaccharide induces the ever more complex syndrome of sepsis and the potential for the development of novel sepsis therapeutics. Conclusions To reduce patient morbidity and mortality, preservation of endothelial function would be central to the management of sepsis. Graphical Abstract
first_indexed 2024-03-10T22:06:08Z
format Article
id doaj.art-300f1b623f7048d695d4d7b850d945bc
institution Directory Open Access Journal
issn 2047-783X
language English
last_indexed 2024-03-10T22:06:08Z
publishDate 2023-09-01
publisher BMC
record_format Article
series European Journal of Medical Research
spelling doaj.art-300f1b623f7048d695d4d7b850d945bc2023-11-19T12:47:17ZengBMCEuropean Journal of Medical Research2047-783X2023-09-0128111610.1186/s40001-023-01301-5Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsisMin Wang0Jun Feng1Daixing Zhou2Junshuai Wang3Department of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Emergency Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Lipopolysaccharide, a highly potent endotoxin responsible for severe sepsis, is the major constituent of the outer membrane of gram-negative bacteria. Endothelial cells participate in both innate and adaptive immune responses as the first cell types to detect lipopolysaccharide or other foreign debris in the bloodstream. Endothelial cells are able to recognize the presence of LPS and recruit specific adaptor proteins to the membrane domains of TLR4, thereby initiating an intracellular signaling cascade. However, lipopolysaccharide binding to endothelial cells induces endothelial activation and even damage, manifested by the expression of proinflammatory cytokines and adhesion molecules that lead to sepsis. Main findings LPS is involved in both local and systemic inflammation, activating both innate and adaptive immunity. Translocation of lipopolysaccharide into the circulation causes endotoxemia. Endothelial dysfunction, including exaggerated inflammation, coagulopathy and vascular leakage, may play a central role in the dysregulated host response and pathogenesis of sepsis. By discussing the many strategies used to treat sepsis, this review attempts to provide an overview of how lipopolysaccharide induces the ever more complex syndrome of sepsis and the potential for the development of novel sepsis therapeutics. Conclusions To reduce patient morbidity and mortality, preservation of endothelial function would be central to the management of sepsis. Graphical Abstracthttps://doi.org/10.1186/s40001-023-01301-5LipopolysaccharideTLR4Endothelial cellsSepsis
spellingShingle Min Wang
Jun Feng
Daixing Zhou
Junshuai Wang
Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis
European Journal of Medical Research
Lipopolysaccharide
TLR4
Endothelial cells
Sepsis
title Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis
title_full Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis
title_fullStr Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis
title_full_unstemmed Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis
title_short Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis
title_sort bacterial lipopolysaccharide induced endothelial activation and dysfunction a new predictive and therapeutic paradigm for sepsis
topic Lipopolysaccharide
TLR4
Endothelial cells
Sepsis
url https://doi.org/10.1186/s40001-023-01301-5
work_keys_str_mv AT minwang bacteriallipopolysaccharideinducedendothelialactivationanddysfunctionanewpredictiveandtherapeuticparadigmforsepsis
AT junfeng bacteriallipopolysaccharideinducedendothelialactivationanddysfunctionanewpredictiveandtherapeuticparadigmforsepsis
AT daixingzhou bacteriallipopolysaccharideinducedendothelialactivationanddysfunctionanewpredictiveandtherapeuticparadigmforsepsis
AT junshuaiwang bacteriallipopolysaccharideinducedendothelialactivationanddysfunctionanewpredictiveandtherapeuticparadigmforsepsis